Landon James Rohowetz is a Miami, Florida based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Landon James Rohowetz is ME167342 for Ophthalmology in Florida. Landon James Rohowetz is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Landon James Rohowetz speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Male
Practice Address:
1611 Nw 12th Ave, Miami, Florida, 33136-1005
Phone:
305-585-5095
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1699302141
NPI Enumeration Date:
25 Mar, 2020
NPI Last Update On:
23 Jul, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Landon James Rohowetz are as mentioned below.
License Number
Specialization
State
Status
ME167342
Ophthalmology
Florida
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1611 Nw 12th Ave, Miami, Florida
Zip:
33136-1005
Phone Number:
305-585-5792
Fax Number:
--
Patients can reach Landon James Rohowetz at 1611 Nw 12th Ave, Miami, Florida or can call to book an appointment on 305-585-5095. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.